Literature DB >> 23888779

[Downregulation of human CCR5 receptor gene expression using artificial microRNAs].

D V Glazkova, A S Vetchinova, E V Bogoslovskaia, Iu A Zhogina, M L Markelov, G A Shipulin.   

Abstract

Chemokine receptor CCR5 is essential for human immunodeficiency virus (HIV) entry into the sensitive cells. The CCR5 inactivation is believed to be one of the promising approaches in HIV therapy, including gene therapy. A powerful mechanism that enables to regulate gene expression is RNA interference which could be exploited to knockdown CCR5 gene. Here, three artificial microRNAs directed against the human CCR5 receptor gene were generated and their silencing activity in indicator cells developed on the basis of the HT1080 cell line was evaluated. Multiplexing of two or more artificial microRNAs in one transcript has been demonstrated to enhance the gene silencing. A 95% reduction of the CCR5 expression has been achieved using the most efficient microRNA combination.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23888779     DOI: 10.7868/s002689841303004x

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  3 in total

1.  Optimization of Critical Hairpin Features Allows miRNA-based Gene Knockdown Upon Single-copy Transduction.

Authors:  Renier Myburgh; Ophélie Cherpin; Erika Schlaepfer; Hubert Rehrauer; Roberto F Speck; Karl-Heinz Krause; Patrick Salmon
Journal:  Mol Ther Nucleic Acids       Date:  2014-10-28       Impact factor: 10.183

2.  Optimization of Polycistronic Anti-CCR5 Artificial microRNA Leads to Improved Accuracy of Its Lentiviral Vector Transfer and More Potent Inhibition of HIV-1 in CD4⁺ T-Cells.

Authors:  Felix Urusov; Dina Glazkova; Denis Omelchenko; Elena Bogoslovskaya; Galina Tsyganova; Katerina Kersting; German Shipulin; Vadim Pokrovsky
Journal:  Cells       Date:  2018-02-04       Impact factor: 6.600

3.  The properties of binding sites of miR-619-5p, miR-5095, miR-5096, and miR-5585-3p in the mRNAs of human genes.

Authors:  Anatoly Ivashchenko; Olga Berillo; Anna Pyrkova; Raigul Niyazova; Shara Atambayeva
Journal:  Biomed Res Int       Date:  2014-08-04       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.